Newsletter Subscription

Progress in Cancer Vaccine Development

First Issue: Progress in Cancer Vaccine Development

Newsletter Details:

For decades, cancer treatment has consisted primarily of surgery, chemotherapy, and radiation. However, therapies (specifically vaccines) are being developed that stimulate the body's innate defense system to target malignant tumors. The Food and Drug Administration (FDA) has previously approved two vaccines that can help prevent cancer caused by: 1) the human papillomavirus (HPV), which causes nearly all cervical cancers; and 2) the hepatitis B virus, which can cause liver cancer. Other vaccines that may prevent or reduce the risk of different cancers are being evaluated in clinical trials. Although the FDA has not yet approved any cancer vaccine as a standard treatment for any previously diagnosed cancer, promising Phase III data for vaccines targeting several tumor types were recently presented at the annual American Society of Clinical Oncology (ASCO) and American Urological Association (AUA) conferences.

STEP 1: Create An Account
  • 6+ Letters/Numbers

About Dynamic Seminars & Consulting, Inc.

DSC has been educating the healthcare industry since 1997. We have continued to provide and present the most dynamic and informative sales and marketing programs for a long list of healthcare professionals. When the Health Insurance Association of America sought customer service training for this leading US industry, they turned to Louis Feuer, MA, MSW, founder of Dynamic Seminars... Read More

About PRIME Education, Inc.

PRIME® is a full-service ACCME Exemplary Accredited provider of innovative CME and CE via program concept, design, development, accreditation and delivery in multimedia venues throughout the health care industry and state and federal governments. Serving the acute, community and long term care healthcare industries since 1994, PRIME® has worked for, consulted for and partnered with... Read More